HEMALASI ApS: Financial statements 2025
CVR: 42924016
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
HEMALASI ApS (CVR 42924016) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 143,121 and a net result of DKK 71,105 compared with DKK 213,974 the year before. That is a decrease of 51.4% compared with the year before. Equity in the 2025 report amounted to DKK 539,399. The solvency ratio was 97.3%.
- Gross Profit
- DKK 143,121
- Profit/Loss
- DKK 71,105
- Equity
- DKK 539,399
- Total Assets
- DKK 554,350
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 143 t. | 71 t. | 539 t. | - |
| 2024 | - | 295 t. | 214 t. | 588 t. | - |
| 2023 | - | 443 t. | 316 t. | 572 t. | - |
| 2022 | - | - | 426 t. | 466 t. | - |
Official annual report
How creditworthy is HEMALASI ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
HEMALASI ApS has published its annual report for 2024. Gross profit came to DKK 294,659, and the net result was DKK 213,974.
About HEMALASI ApS
HEMALASI ApS is a Danish company of the type Anpartsselskab based in Hedensted, founded in 2021. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Lars Zederkof. The company's owners include Helle Laursen, Lars Zederkof and Signe Forsberg Zederkof. In 2025, the company reported a gross profit of DKK 143,121 and a net result of DKK 71,105 compared with DKK 213,974 the year before. Equity in the 2025 report amounted to DKK 539,399.